SEPARATION AGREEMENT AND RELEASE OF CLAIMS (Agreement provided to Employee November 7, 2006)
Exhibit 10.41
SEPARATION AGREEMENT AND RELEASE OF CLAIMS
(Agreement provided to Employee November 7, 2006)
(Agreement provided to Employee November 7, 2006)
If you choose to accept Avanir Pharmaceuticals (“The Company”) Severance Package, please sign
and return this Agreement to ▇▇▇▇▇▇▇ Hope-▇▇▇▇▇, Vice President Human Resources, by no later than
5:00 p.m. on November 29th. You may scan and e-mail the signed Agreement to ▇▇▇▇▇▇▇ Hope-▇▇▇▇▇ at
▇▇▇▇▇-▇▇▇▇▇@▇▇▇▇▇▇.▇▇▇. and mail the original to her at The Company’s offices at ▇▇▇ ▇▇▇▇▇▇▇▇▇▇,
▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, telephone ▇▇▇.▇▇▇.▇▇▇▇.
RECITALS
WHEREAS, ▇▇. ▇▇▇▇ will conclude his employment with the Company, as described herein;
WHEREAS, after the conclusion of ▇▇. ▇▇▇▇’▇ employment with the Company, ▇▇. ▇▇▇▇ wishes to
serve as a consultant to the Company, and the Company wishes to retain ▇▇. ▇▇▇▇ as a consultant;
and
WHEREAS, each of the Parties to this Agreement desires an amicable separation of employment
and to resolve any and all claims, disputes, issues, or matters that were asserted or could be
asserted;
NOW THEREFORE, in consideration of the promises, covenants and agreements set forth herein,
and subject to the terms and conditions set forth below, the Parties desire to, and hereby do,
agree as follows:
| 1. | ▇▇. ▇▇▇▇’▇ employment with the Company will terminate effective November 7, 2006 (the “Termination Date”); | ||
| 2. | For a term of twelve (12) months following the Termination Date (the “Consulting Period”), the Company will retain ▇▇. ▇▇▇▇ and ▇▇. ▇▇▇▇ agrees to provide services as an independent contractor on the terms provided in the independent contractor agreement attached hereto as Exhibit A. The Parties agree that, concurrent with the signing of this Agreement, they will sign the independent contract agreement that is attached hereto as Exhibit A. | ||
| 3. | In exchange for agreeing to be bound by the terms of this Agreement and the attached Consulting Agreement, the Company will provide ▇▇. ▇▇▇▇ with the following separation payments to which she/he otherwise would not be entitled: |
| • | Thirty-nine (39) weeks of separation pay, calculated based on ▇▇▇▇’▇ current base salary, less all the required withholdings and taxes. | ||
| • | If ▇▇▇▇ chooses to elect continuation of coverage under federal law known as COBRA, the Company will continue to pay his medical, dental and vision premium through 31 August 2007, unless he becomes eligible for coverage |
| under another group insurance plan before that date. Effective 01 September 2007, COBRA payments become ▇▇▇▇’▇ responsibility. | |||
| • | Outplacement benefits as approved and offered through Right Management Consultants. |
The payment described in this paragraph will become due fourteen (14) days after the
Effective Date of this Agreement, as defined herein, provided that Employee complies
with his obligations under Section (e) below.
4. Release.
4.1 ▇▇▇▇, for himself and his heirs, agents, assigns, executors, successors and each of them,
unconditionally, irrevocably and absolutely releases and discharges the Company, and any parent and
subsidiary corporations, divisions, and affiliated corporations, partnerships or other affiliated
entities of the Company, past and present, as well as the Company’s employees, officers, directors,
agents, predecessors, successors and assigns (collectively “Released Parties”), from all claims
related in any way to the transactions or occurrences between them to date, to the fullest extent
permitted by law, including, but not limited to, ▇▇▇▇’▇ employment with the Company, the
termination of his employment, and all other losses, liabilities, claims, demands and causes of
action, known or unknown, suspected or unsuspected, arising directly or indirectly out of or in any
way connected with ▇▇▇▇’▇ employment with the Company and the termination of that employment. This
release is intended to have the broadest possible application permitted by law and includes, but is
not limited to, any tort, contract, common law, constitutional or statutory claims and all claims
for attorneys’ fees, costs and expenses. Notwithstanding the foregoing, this release shall not
serve as a waiver of ▇▇▇▇’▇ rights to (i) vested benefits such as the Avanir Pharmaceuticals
Employee Savings and Protection Plan, (ii) workers compensation or unemployment benefits,
(iii) statutorily-required indemnification under California Labor Code Section 2802 or any
comparable provisions of other states’ laws, or (iv) any other benefits or claims that cannot be
released as a matter of law.
4.2 ▇▇▇▇ declares and represents that he intends this Agreement to be complete and not subject
to any claim of mistake, and that the release herein expresses a full and complete release and,
regardless of the adequacy or inadequacy of the consideration, the Parties intend the release to be
final and complete. The Parties execute this release with the full knowledge that this release
covers all possible claims against the Released Parties, to the fullest extent permitted by law.
5. Acknowledgement of Understanding. ▇▇▇▇ and The Company acknowledge that they may
discover facts or law different from, or in addition to, the facts or law that they know or believe
to be true with respect to the claims released in this Agreement and agree, nonetheless, that this
Agreement and the release contained in it shall be and remain effective in all respects
notwithstanding such different or additional facts or the discovery of them. ▇▇▇▇ and The Company
expressly acknowledge and agree that ▇▇▇▇’▇ rights under Section 1542 of the California Civil Code
and any comparable provisions of other states’ and federal law are expressly waived. That section
provides:
2
A general release does not extend to claims which the creditor does
not know or suspect to exist in his favor at the time of executing
the release, which if known by him must have materially affected his
settlement with the debtor.
6. Pursuit of Released Claims. ▇▇▇▇ represents that, as of the date of this
Agreement, he has not filed any lawsuits, charges, complaints, petitions, claims or other
accusatory pleadings against Released Parties in any court or with any governmental agency. ▇▇▇▇
further agrees that, to the fullest extent permitted by law, he/she will not prosecute, nor allow
to be prosecuted on his behalf, in any court, whether state or federal, any claim or demand of any
type related to the matters released above, it being the intention of ▇▇▇▇ that with the execution
of this release, Released Parties will be absolutely, unconditionally and forever discharged of and
from all obligations to or on behalf of ▇▇▇▇ related in any way to the matters discharged herein.
▇▇▇▇ further represents that he has not assigned any claim he may have against Released Parties to
any other person or entity. Nothing in this Agreement limits ▇▇▇▇’▇ right to file a charge or
complaint with any state or federal agency or to participate or cooperate in such a matter, but
▇▇▇▇ acknowledges that he is not entitled to any other monies other than those payments described
in this Agreement.
7. Return of Company Property. By signing this Agreement, ▇▇▇▇ represents and
warrants that he will have returned to the Company on or before the Effective Date of this
Agreement, all Company property, including all originals and copies of documents removed from The
Company’s premises at any time during his employment with The Company. ▇▇▇▇ will not be entitled
to the Severance Package described in Paragraph 3 herein unless and until all such property is
returned to The Company.
8. Expense Reimbursement. By signing this Agreement, ▇▇▇▇ agrees to submit all
outstanding reimbursements he incurred as an employee of the Company to the Company on or before
the Effective Date of this Agreement.
9. Nondisparagement. ▇▇▇▇ will not make any voluntary statements, written or verbal,
or cause or encourage others to make any such statements that defame, disparage or in any way
criticize the Company’s business reputation, practices or conduct.
10. Arbitration of Disputes and Enforcement of Agreement.
10.1 ▇▇▇▇ and the Company agree to resolve any claims they may have against each other or that
▇▇▇▇ has with any other Released Party through final and binding arbitration. This agreement to
arbitrate applies to any and all disputes about the validity, interpretation, or effect of this
Agreement or alleged violations of it and whether a particular claim is covered by this Agreement
(“Arbitrable Claims”). Except as provided in Section (h)(3) below, arbitration shall be the
exclusive remedy for any such claim or dispute, and the parties expressly waive their rights to a
jury trial on any such claim or dispute. Arbitration shall be conducted through JAMS or, if JAMS
is not available, through another arbitration provider mutually acceptable to the parties.
However, either party may bring an action in court to compel arbitration under this Agreement or to
enforce an arbitration award. The Federal Arbitration Act shall govern the interpretation and
enforcement of this section. If a court or arbitrator finds the Federal
3
Arbitration Act does not govern, then California law shall govern the interpretation and
enforcement of this section.
10.2 In any arbitration, legal proceeding or other proceeding brought to enforce or interpret
the terms of this Agreement, the prevailing party shall be entitled to recover reasonable
attorneys’ fees and costs. In addition, should ▇▇▇▇ or the Company attempt to resolve any claim
waived by this Agreement or pursue any Arbitrable Claim by any method other than arbitration
(except to the extent allowed in Section (h)(3) below) the responding party will be entitled to
recover from the initiating party all damages, costs, expenses, and attorneys’ fees incurred as a
result of that breach.
10.3 The requirement to arbitrate disputes shall not preclude ▇▇▇▇ from filing a charge or
with a state or federal government agency. However, ▇▇▇▇ acknowledges that he is not entitled to
any other monies other than those payments described in this Agreement.
11. Older Workers’ Benefit Protection Act. This Agreement is intended to satisfy the
requirements of the Older Workers’ Benefit Protection Act, 29 U.S.C. sec. 626(f). The following
general provisions, along with the other provisions of this Agreement, are agreed to for this
purpose:
11.1 ▇▇▇▇ acknowledges and agrees that he has read and understands the terms of this
Agreement.
11.2 ▇▇▇▇ acknowledges that this Agreement advises him in writing that he may consult with an
attorney before executing this Agreement, and that he has obtained and considered such legal
counsel as he deems necessary, such that he is entering into this Agreement freely, knowingly and
voluntarily.
11.3 ▇▇▇▇ acknowledges that he has been given at least twenty-one (21) days in which to
consider whether or not to enter into this Agreement. ▇▇▇▇ understands that, at his option, he may
elect not to use the full twenty-one (21) day period.
11.4 ▇▇▇▇ shall have seven (7) days after signing this Agreement to revoke this Agreement.
This Agreement will not become effective until the expiration of the revocation period. ▇▇▇▇’▇
revocation of this Agreement must be in writing and received by ▇▇▇▇▇▇▇ Hope-▇▇▇▇▇, Vice President
Human Resources, no later than 5:00 p.m. on the seventh day in order to be effective. If Employee
does not revoke acceptance within the seven (7) day period, this Agreement will become fully
effective and enforceable on the eighth day after the Agreement is signed (the “Effective Date”).
11.5 ▇▇▇▇ does not waive or release any rights or claims that he may have under the Age
Discrimination in Employment Act that arise after the execution of this Agreement. ▇▇▇▇ is not
waiving his right to file a complaint or charge with the EEOC (including a challenge to the
validity of this Agreement) or participate in any investigation or proceeding conducted by the
EEOC.
12. Miscellaneous. This Agreement and the exhibit hereto sets forth the entire
agreement between ▇▇▇▇ and the Company pertaining to the subject matter of this Agreement.
4
This Agreement may not be modified or canceled in any manner except by a writing signed by
both ▇▇▇▇ and an authorized Company official. ▇▇▇▇ acknowledges that the Company has made no
representations or promises to him, other than those in this Agreement. If any provision in this
Agreement is found to be unenforceable, that provision will be enforced to the greatest extent
permitted by law and all other provisions will remain fully enforceable. This Agreement binds the
Parties and their heirs, administrators, representatives, executors, successors, and assigns. This
Agreement shall be construed as a whole according to its fair meaning. It shall not be construed
strictly for or against ▇▇▇▇ or the Released Parties. Unless the context indicates otherwise, the
term “or” shall be deemed to include the term “and” and the singular or plural number shall be
deemed to include the other. This Agreement shall be governed by the law of the State of
California, excluding its laws relating to the choice of laws.
13. Counterparts. This Agreement may be executed by facsimile or facsimile signature,
and in separate counterparts, each of which shall be deemed an original but all of which, when
taken together, shall constitute one and the same instrument.
Please read this Agreement and carefully consider all of its provisions before signing it.
This Agreement includes a release of known and unknown claims. This Agreement also includes an
arbitration clause in which both parties waive any rights they may have to trial by jury with
regard to arbitrable claims. If you wish, you should take advantage of the twenty-one (21) day
consideration period provided by this Agreement and consult your attorney.
Date
|
11/28/2006 | /s/ ▇▇▇▇▇ ▇. ▇▇▇▇ | ||||||
| Employee | ||||||||
Date
|
07 Nov 06 | /s/ ▇▇▇▇▇▇▇ Hope-▇▇▇▇▇ | ||||||
| Company |
5
EXHIBIT A
TO SEPARATION AGREEMENT AND RELEASE OF CLAIMS
TO SEPARATION AGREEMENT AND RELEASE OF CLAIMS
INDEPENDENT CONTRACTOR AGREEMENT
07 November 2006
07 November 2006
This Independent Contractor Agreement (“Agreement”) is entered into by and between Avanir
Pharmaceuticals, a California corporation (“Avanir” or the “Company”), and ▇▇▇▇▇ ▇. ▇▇▇▇
(collectively referred to as the “Parties”).
WHEREAS, ▇▇. ▇▇▇▇ will terminate his employment with Avanir, as described in the Separation
Agreement and Release entered into by ▇▇. ▇▇▇▇ and Avanir (the “Separation Agreement”);
WHEREAS, after the conclusion of ▇▇. ▇▇▇▇’▇ employment with Avanir, ▇▇. ▇▇▇▇ wishes to serve
as a consultant to Avanir, and Avanir wishes to retain ▇▇. ▇▇▇▇ as a consultant; and
WHEREAS, each of the Parties to this Agreement desires, through a release of claims, to
resolve any and all claims, disputes, issues, or matters that were asserted or could have been
asserted or could be asserted.
NOW, THEREFORE, in consideration of the mutual promises made herein, the Parties hereby agree
as follows:
1. Consultancy. ▇▇. ▇▇▇▇ shall serve as a consultant to the Company for a twelve
(12)-month period commencing on the date ▇▇. ▇▇▇▇’▇ employment with Avanir concludes pursuant to
the Separation Agreement and concluding twelve (12) months thereafter (“Consulting Period”).
2. Scope of Work. During the Consulting Period, ▇▇. ▇▇▇▇ agrees to make himself
available at reasonable times and places to perform consulting services as requested by the
Company. Such services include, but are not limited to, providing advice and assistance regarding
special projects, conference appearances or any other matter consistent with ▇▇. ▇▇▇▇’▇ background,
skills and experience, as requested by the Chief Executive Officer of Avanir. ▇▇. ▇▇▇▇ further
agrees that during the Consulting Period he will make himself available and use his best efforts in
the transition of his former duties to designated representatives or employees of the Company.
Such efforts include, but are not limited to, providing corporate records, files and other
materials. Except as otherwise requested by the Company, ▇▇. ▇▇▇▇ shall not perform his duties on
the Company’s premises, nor will he be provided with use of the Company’s telephones, voice-mail,
e-mail, internet or other Company property.
3. Consulting Fee. As compensation for providing consulting services during the
Consulting Period, ▇▇. ▇▇▇▇ will receive a $105.30 per hour of consulting service provided. If
Avanir terminates ▇▇. ▇▇▇▇’▇ consultancy prior to the expiration of the Consulting Period,
Avanir will continue to pay ▇▇. ▇▇▇▇ any unpaid portion in accordance with the payment
schedule set forth above. Notwithstanding the preceding sentence or any other provision of this
Agreement, Avanir may terminate ▇▇. ▇▇▇▇’▇ consultancy and not make any further payments to
▇▇. ▇▇▇▇ should ▇▇. ▇▇▇▇ violate any provision of this Agreement, including but not limited to the
provisions of Section 5, below. The Company shall reimburse ▇▇. ▇▇▇▇ for reasonable expenses
incurred on behalf of the Company during the Consulting Period, provided that such expenses are
approved in advance and substantiated in accordance with Company policies.
4. Benefits. As an independent contractor, ▇▇. ▇▇▇▇ is not entitled to any Company
employee benefits, other than as outlined in the Separation Agreement and Release of Claims.
5. Noncompetition. During the Consulting Period, ▇▇. ▇▇▇▇ may engage in other
employment, consulting or businesses, provided such activity does not preclude him from making
himself reasonably available to provide consulting services to the Company as provided above.
6. Nonsolicitation. Through 08 August 2007, ▇▇. ▇▇▇▇ will not either directly or
indirectly solicit, induce, recruit or encourage any of the Company’s employees or consultants to
terminate their relationship with the Company, or attempt to solicit, induce, recruit, encourage or
take away employees or consultants of the Company, either for himself or for any other person or
entity.
7. Confidential Information. ▇▇. ▇▇▇▇ understands and agrees that his obligations to
the Company under the Employee Invention Assignment, Patent and Confidential Information Agreement
entered into between ▇▇. ▇▇▇▇ and the Company on 07 April 1999 (the “Proprietary Agreement”) shall
continue through the Consulting Period and shall survive the termination of his relationship with
the Company under this Agreement.
8. Breach of this Agreement. ▇▇. ▇▇▇▇ acknowledges that upon his material breach of
any provision of this Agreement or the Proprietary Agreement, the Company would sustain irreparable
harm from such breach, and, therefore, ▇▇. ▇▇▇▇ agrees that in addition to any other remedies which
the Company may have under this Agreement, the Proprietary Agreement or otherwise, the Company
shall be entitled to obtain equitable relief (without the posting of a bond) including specific
performance, injunctions and restraining ▇▇. ▇▇▇▇ from committing or continuing any such violation
of this Agreement or the Proprietary Agreement.
9. Independent Contractor Status. In performance of services under this Agreement,
▇▇. ▇▇▇▇ will be an independent contractor of, and is not an agent or employee of, and has no
authority to bind, the Company by contract or otherwise.
10. Employment Taxes. ▇▇. ▇▇▇▇ agrees that he shall report as self-employment income
all compensation he receives pursuant to this Agreement and is solely responsible for any taxes,
withholdings and similar statutory obligations. ▇▇. ▇▇▇▇ will indemnify the Company and its
officers, directors, shareholders and employees and agents and will hold it and them harmless from
any and all claims made by any entity on account of an actual or alleged failure by ▇▇. ▇▇▇▇ to
satisfy any such tax or withholding obligations.
2
11. Authority. The Company represents and warrants that the undersigned has the
authority to act on behalf of the Company and to bind the Company and all who may claim through it
to the terms and conditions of this Agreement. ▇▇. ▇▇▇▇ represents and warrants that he has the
capacity to act on his own behalf and on behalf of all whom might claim through him to bind them to
the terms and conditions of this Agreement. Each Party warrants and represents that there are no
liens or claims of lien or assignments in law or equity or otherwise of or against any of the
claims or causes of action released herein.
12. No Representations. Neither Party has relied upon any representations or
statements made by the other Party hereto which are not specifically set forth in this Agreement
the Separation Agreement or the Proprietary Agreement.
13. Severability. In the event that any provision hereof becomes or is declared by a
court or other tribunal of competent jurisdiction to be illegal, unenforceable or void, this
Agreement shall continue in full force and effect, and any such provision will be limited or
eliminated to the minimum extent necessary so that this Agreement shall otherwise remain in full
force and effect and enforceable.
14. Entire Agreement. This Agreement, and the exhibit hereto, represent the entire
agreement and understanding between the Company and ▇▇. ▇▇▇▇ concerning his consultancy with the
Company, and supersede and replace any and all prior agreements and understandings concerning
▇▇. ▇▇▇▇’▇ relationship with the Company and his compensation by the Company, with the exception of
the Proprietary Agreement and the Separation Agreement. To the extent any provision of the
Proprietary Agreement may conflict with any provision of this Agreement or the Separation
Agreement, this Agreement and the Separation Agreement shall prevail.
15. No Oral Modification. This Agreement may only be amended in a writing signed by
▇▇. ▇▇▇▇ and the Company.
16. Governing Law. This Agreement shall be governed by the laws of the State of
California, without regard to its conflicts of law provisions.
17. Effective Date. This Agreement shall he effective upon the Effective Date as
defined in the Separation Agreement and Release of Claims to which this Agreement is an exhibit.
18. Counterparts. This Agreement may be executed in counterparts, and each
counterpart shall have the same force and effect as an original and shall constitute an effective,
binding agreement on the part of each of the undersigned.
19. Assignment. This Agreement may not be assigned by ▇▇. ▇▇▇▇ or the Company without
the prior written consent of the Company. Notwithstanding the foregoing, this Agreement may be
assigned by the Company to a corporation controlling, controlled by or under common control with
the Company without the consent of ▇▇. ▇▇▇▇.
20. Voluntary Execution of Agreement. This Agreement is executed voluntarily and
without any duress or undue influence on the part or behalf of the Parties hereto, with the full
intent of releasing all claims. The Parties acknowledge that:
3
a. they have read this Agreement;
b. they have been represented in the preparation, negotiation, and execution of this Agreement
by legal counsel of their own choice or that they have voluntarily declined to seek such counsel;
c. they understand the terms and consequences of this Agreement and of the releases it
contains; and
d. they are fully aware of the legal and binding effect of this Agreement.
IN WITNESS WHEREOF, each of the Parties has executed this Agreement, in the case of the
Company by its duly authorized officer as of the day and year first written above.
| AVANIR PHARMACEUTICALS | ||||||
| By | ▇▇▇▇▇▇▇ Hope-▇▇▇▇▇ 07 Nov 06 | |||||
| ▇▇▇▇▇▇▇ Hope-▇▇▇▇▇ | ||||||
| ▇▇▇▇▇ ▇. ▇▇▇▇, an individual | ||||||
| ▇▇▇▇▇ ▇. ▇▇▇▇ | ||||||
| ▇▇▇▇▇ ▇. ▇▇▇▇ | ||||||
4